These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 36826438)

  • 1. Senescence and Immunotherapy: Redundant Immunomodulatory Pathways Promote Resistance.
    Oesterreich S; Aird KM
    Cancer Immunol Res; 2023 Apr; 11(4):401-404. PubMed ID: 36826438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular senescence and the tumour microenvironment.
    Takasugi M; Yoshida Y; Ohtani N
    Mol Oncol; 2022 Sep; 16(18):3333-3351. PubMed ID: 35674109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aging microenvironment and antitumor immunity for geriatric oncology: the landscape and future implications.
    Zhao B; Wu B; Feng N; Zhang X; Zhang X; Wei Y; Zhang W
    J Hematol Oncol; 2023 Mar; 16(1):28. PubMed ID: 36945046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reshaping of the tumor microenvironment by cellular senescence: An opportunity for senotherapies.
    D'Ambrosio M; Gil J
    Dev Cell; 2023 Jun; 58(12):1007-1021. PubMed ID: 37339603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overcoming the senescence-associated secretory phenotype (SASP): a complex mechanism of resistance in the treatment of cancer.
    Chambers CR; Ritchie S; Pereira BA; Timpson P
    Mol Oncol; 2021 Dec; 15(12):3242-3255. PubMed ID: 34137158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Senescence and the tumor-immune landscape: Implications for cancer immunotherapy.
    Chibaya L; Snyder J; Ruscetti M
    Semin Cancer Biol; 2022 Nov; 86(Pt 3):827-845. PubMed ID: 35143990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of senescence on the tumour microenvironment and response to therapy.
    Reynolds LE; Maallin S; Haston S; Martinez-Barbera JP; Hodivala-Dilke KM; Pedrosa AR
    FEBS J; 2024 Jun; 291(11):2306-2319. PubMed ID: 37873605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct phenotypes and 'bystander' effects of senescent tumour cells induced by docetaxel or immunomodulatory cytokines.
    Sapega O; Mikyšková R; Bieblová J; Mrázková B; Hodný Z; Reiniš M
    Int J Oncol; 2018 Nov; 53(5):1997-2009. PubMed ID: 30226595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor cell senescence-induced macrophage CD73 expression is a critical metabolic immune checkpoint in the aging tumor microenvironment.
    Deng Y; Chen Q; Yang X; Sun Y; Zhang B; Wei W; Deng S; Meng J; Hu Y; Wang Y; Zhang Z; Wen L; Huang F; Wan C; Yang K
    Theranostics; 2024; 14(3):1224-1240. PubMed ID: 38323313
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapy-Induced Cellular Senescence: Potentiating Tumor Elimination or Driving Cancer Resistance and Recurrence?
    Liu Y; Lomeli I; Kron SJ
    Cells; 2024 Jul; 13(15):. PubMed ID: 39120312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular senescence and SASP in tumor progression and therapeutic opportunities.
    Dong Z; Luo Y; Yuan Z; Tian Y; Jin T; Xu F
    Mol Cancer; 2024 Aug; 23(1):181. PubMed ID: 39217404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockades of effector T cell senescence and exhaustion synergistically enhance antitumor immunity and immunotherapy.
    Liu X; Si F; Bagley D; Ma F; Zhang Y; Tao Y; Shaw E; Peng G
    J Immunother Cancer; 2022 Oct; 10(10):. PubMed ID: 36192086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of the senescent microenvironment on tumorigenesis: Insights for cancer therapy.
    Zhang W; Zhang K; Shi J; Qiu H; Kan C; Ma Y; Hou N; Han F; Sun X
    Aging Cell; 2024 May; 23(5):e14182. PubMed ID: 38650467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of cellular senescence and SASP in tumour microenvironment.
    Takasugi M; Yoshida Y; Hara E; Ohtani N
    FEBS J; 2023 Mar; 290(5):1348-1361. PubMed ID: 35106956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Senescence-associated secretory factors induced by cisplatin in melanoma cells promote non-senescent melanoma cell growth through activation of the ERK1/2-RSK1 pathway.
    Sun X; Shi B; Zheng H; Min L; Yang J; Li X; Liao X; Huang W; Zhang M; Xu S; Zhu Z; Cui H; Liu X
    Cell Death Dis; 2018 Feb; 9(3):260. PubMed ID: 29449532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromatin basis of the senescence-associated secretory phenotype.
    Hao X; Wang C; Zhang R
    Trends Cell Biol; 2022 Jun; 32(6):513-526. PubMed ID: 35012849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Senescent cells and SASP in cancer microenvironment: New approaches in cancer therapy.
    Özdemir A; Şimay Demir YD; Yeşilyurt ZE; Ark M
    Adv Protein Chem Struct Biol; 2023; 133():115-158. PubMed ID: 36707199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic and scalable assessment of the senescence-associated secretory phenotype (SASP).
    Malaquin N; Rodier F
    Methods Cell Biol; 2024; 181():181-195. PubMed ID: 38302239
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Zhang JW; Zhang D; Yin HS; Zhang H; Hong KQ; Yuan JP; Yu BP
    Gut Microbes; 2023; 15(1):2197836. PubMed ID: 37017266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitofusin 1 silencing decreases the senescent associated secretory phenotype, promotes immune cell recruitment and delays melanoma tumor growth after chemotherapy.
    Tarallo D; Martínez J; Leyva A; Mónaco A; Perroni C; Tassano M; Gambini JP; Cappetta M; Durán R; Moreno M; Quijano C
    Sci Rep; 2024 Jan; 14(1):909. PubMed ID: 38195762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.